Eternygen GmbH:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eternygen GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10816
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eternygen GmbH (Eternygen) is a drug discovery company that offers research and development of innovative drugs for dietary-related metabolic diseases. The company’s product development portfolio includes novel small molecule inhibitors, developed against the sodium coupled citrate transporter NaCT. It also research and develops NaCT a regulator of lipid metabolism involved in the pathogenesis. Eternygen provides drugs for diseases such as diabetes mellitus, fatty liver, and obesity. The company’s proprietary molecules work on glucose metabolism and hepatic lipid oxidation and acts as a therapeutic target by influencing the mammalian energy metabolism. It works in collaboration with other contract research organizations for drug discovery and pre-clinical development in the field of metabolic diseases. Eternygen is headquartered in Berlin City, Germany.

Eternygen GmbH – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eternygen GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eternygen GmbH, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Eternygen Raises USD8.4 Million in Series A Financing 10
Eternygen Raises Funds Through Seed Financing Round 11
Partnerships 12
Evotec Enters into Co-Development Agreement with Eternygen 12
Eternygen GmbH – Key Competitors 13
Eternygen GmbH – Key Employees 14
Eternygen GmbH – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Eternygen GmbH, Pharmaceuticals & Healthcare, Key Facts 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eternygen GmbH, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eternygen GmbH, Deals By Therapy Area, 2012 to YTD 2018 8
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eternygen Raises USD8.4 Million in Series A Financing 10
Eternygen Raises Funds Through Seed Financing Round 11
Evotec Enters into Co-Development Agreement with Eternygen 12
Eternygen GmbH, Key Competitors 13
Eternygen GmbH, Key Employees 14

List of Figures
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eternygen GmbH, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Eternygen GmbH:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • McKesson Corporation:企業のM&A・事業提携・投資動向
    McKesson Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's McKesson Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Black Hills Corporation (BKH):電力:M&Aディール及び事業提携情報
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …
  • Trilogy Energy Corp. (TET):企業のM&A・提携動向(石油・ガス分野)
    Summary Trilogy Energy Corp. (TET), formerly Trilogy Energy Trust is an energy corporation that acquires, develops, produces and sells crude oil, natural gas, and natural gas liquids. The corporation separates its business operations based on the area of operation that comprise Natural Gas Liquids R …
  • EDF Energies Nouvelles S.A.:企業のM&A・提携・投資分析
    EDF Energies Nouvelles S.A. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EDF Energies Nouvelles S.A. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acq …
  • Gujarat State Electricity Corporation Ltd:発電所・企業SWOT分析
    Gujarat State Electricity Corporation Ltd – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inform …
  • New Carolin Gold Corp.:企業の戦略・SWOT・財務分析
    SummaryNew Carolin Gold Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Caleres, Inc.:企業の戦略・SWOT・財務分析
    SummaryCaleres, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • DS Smith Plc:企業のM&A・提携・投資分析
    DS Smith Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's DS Smith Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • ZhongDe Waste Technology AG (ZEF):企業の財務及び戦略的SWOT分析
    Summary ZhongDe Waste Technology AG (ZhongDe) is a waste management company that designs, finances, constructs and operates energy-from-waste plants. The company manufactures mass burn units. ZhongDe utilizes various technologies such as grate, fluidized bed, pyrolytic and rotary kiln. Its projects …
  • Talisman Energy Norge AS:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Talisman Energy Norge AS Merger …
  • AEVIS Victoria SA (AEVS):企業のM&A・提携動向(医療分野)
    Summary AEVIS Victoria SA (AEVIS), a subsidiary of Medical Research, Services & Investments SA is a holding company that offers investment services. The company invests in healthcare, hospitality, life sciences and lifestyle. It develops outpatient surgical centres, medical network, center for preve …
  • Colorlab Custom Cosmetics, Inc :企業の戦略・SWOT・財務分析
    SummaryColorlab Custom Cosmetics, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the compa …
  • Imperial College London(製薬・医療分野):企業M&A動向
    Summary Imperial College London (Imperial) is an educational institution. It offers undergraduate and postgraduate courses in science and technology, agriculture, business, the humanities, and medicine. The institute operates the departments such as advanced biotechnology centre, aeronautics, airway …
  • Eversource Energy (ES):企業のM&A・提携動向(発電分野)
    Summary Eversource Energy (Eversource), formerly, Northeast Utilities, is a public utility company which operates New England’s largest energy delivery system. It undertakes the supply of electricity and natural gas to customers in Connecticut, New Hampshire and Massachusetts through its subsidiarie …
  • Noble Energy, Inc.:戦略・SWOT・企業財務分析
    Noble Energy, Inc. - Strategy, SWOT and Corporate Finance Report Summary Noble Energy, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Suda Ltd (SUD):企業のM&A・提携動向(医療機器分野)
    Summary Suda Ltd (Suda) is a drug delivery company that offers oro-mucosal administration solutions. The company offers products such as artimist, zolpimist, SUD-001, SUD-002, SUD-003, SUD-004 and SUD-005. Its artimist is a sub-lingual spray for the treatment of p. falciparum severe paediatric malar …
  • Natera Inc (NTRA):企業の財務・戦略的SWOT分析
    Summary Natera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis. The company offers products such as panorama prenatal testing, pre-implantation genetic testing, miscarriage testing, g …
  • Marksmen Energy Inc (MAH):石油・ガス:M&Aディール及び事業提携情報
    Summary Marksmen Energy Inc (Marksmen Energy), formerly Marksmen Resources Ltd is an oil and gas exploration and development company that explores and develops light oil assets in Ohio. The company acquires, explores, operates, mines, manages, produces and develops oil and gas properties in Western …
  • Blade Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Blade Therapeutics Inc (Blade Therapeutics) is a biopharmaceutical company which develops novel anti-fibrotic therapies to treat various fibrotic disorders. Its lead program is a small molecule inhibitor targeting an intracellular cysteine protease associated with fibrosis across diverse ind …
  • Perpetual Energy, Inc. (formerly Paramount Energy Trust):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Perpetual Energy, Inc. (formerl …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆